Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group

Mutations of the epidermal growth factor receptor (EGFR) are the strongest predictive factor for response to EGFR tyrosine kinase inhibitors (TKIs), such as gefitinib and erlotinib. EGFR TKIs are approved in Korea as a first-line treatment for lung cancer patients with mutated EGFR. Rapid and accura...

Descripción completa

Detalles Bibliográficos
Autores principales: Shim, Hyo Sup, Chung, Jin-Haeng, Kim, Lucia, Chang, Sunhee, Kim, Wan-Seop, Lee, Geon Kook, Jung, Soon-Hee, Jang, Se Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and The Korean Society for Cytopathology 2013
Materias:
Review & Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647121/
https://www.ncbi.nlm.nih.gov/pubmed/23667368
http://dx.doi.org/10.4132/KoreanJPathol.2013.47.2.100

Ejemplares similares

Ejemplares similares